Format
Sort by

Send to

Choose Destination

Search results

Items: 15

1.

Enhanced Requirement for TNFR2 in Graft Rejection Mediated by Low-Affinity Memory CD8+ T Cells during Heterologous Immunity.

Krummey SM, Chen CW, Guasch SA, Liu D, Wagener M, Larsen CP, Ford ML.

J Immunol. 2016 Sep 1;197(5):2009-15. doi: 10.4049/jimmunol.1502680.

PMID:
27481849
2.

Tregs Hold On To Ceramide.

Krummey SM, Ford ML.

Am J Transplant. 2016 Jul;16(7):1945. doi: 10.1111/ajt.13901. No abstract available.

PMID:
27348801
3.

Low-Affinity Memory CD8+ T Cells Mediate Robust Heterologous Immunity.

Krummey SM, Martinez RJ, Andargachew R, Liu D, Wagener M, Kohlmeier JE, Evavold BD, Larsen CP, Ford ML.

J Immunol. 2016 Mar 15;196(6):2838-46. doi: 10.4049/jimmunol.1500639.

PMID:
26864034
4.

New insights into T-cell cosignaling in allograft rejection and survival.

Krummey SM, Ford ML.

Curr Opin Organ Transplant. 2015 Feb;20(1):43-8. doi: 10.1097/MOT.0000000000000151. Review.

5.

Braking bad: novel mechanisms of CTLA-4 inhibition of T cell responses.

Krummey SM, Ford ML.

Am J Transplant. 2014 Dec;14(12):2685-90. doi: 10.1111/ajt.12938. Review.

6.

High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept.

Krummey SM, Cheeseman JA, Conger JA, Jang PS, Mehta AK, Kirk AD, Larsen CP, Ford ML.

Am J Transplant. 2014 Mar;14(3):607-14.

7.

SAP facilitates recruitment and activation of LCK at NTB-A receptors during restimulation-induced cell death.

Katz G, Krummey SM, Larsen SE, Stinson JR, Snow AL.

J Immunol. 2014 May 1;192(9):4202-9. doi: 10.4049/jimmunol.1303070.

8.

Candida-elicited murine Th17 cells express high Ctla-4 compared with Th1 cells and are resistant to costimulation blockade.

Krummey SM, Floyd TL, Liu D, Wagener ME, Song M, Ford ML.

J Immunol. 2014 Mar 1;192(5):2495-504. doi: 10.4049/jimmunol.1301332.

9.

2B4 (CD244) induced by selective CD28 blockade functionally regulates allograft-specific CD8+ T cell responses.

Liu D, Krummey SM, Badell IR, Wagener M, Schneeweis LA, Stetsko DK, Suchard SJ, Nadler SG, Ford ML.

J Exp Med. 2014 Feb 10;211(2):297-311. doi: 10.1084/jem.20130902.

10.

Heterogeneity within T Cell Memory: Implications for Transplant Tolerance.

Krummey SM, Ford ML.

Front Immunol. 2012 Mar 1;3:36. doi: 10.3389/fimmu.2012.00036.

11.

The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease.

Liu Z, Lee J, Krummey S, Lu W, Cai H, Lenardo MJ.

Nat Immunol. 2011 Oct 9;12(11):1063-70. doi: 10.1038/ni.2113.

12.

The power and the promise of restimulation-induced cell death in human immune diseases.

Snow AL, Pandiyan P, Zheng L, Krummey SM, Lenardo MJ.

Immunol Rev. 2010 Jul;236:68-82. doi: 10.1111/j.1600-065X.2010.00917.x. Review.

13.

Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency.

Snow AL, Marsh RA, Krummey SM, Roehrs P, Young LR, Zhang K, van Hoff J, Dhar D, Nichols KE, Filipovich AH, Su HC, Bleesing JJ, Lenardo MJ.

J Clin Invest. 2009 Oct;119(10):2976-89. doi: 10.1172/JCI39518.

14.
15.

Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.

Deeb KK, Michalowska AM, Yoon CY, Krummey SM, Hoenerhoff MJ, Kavanaugh C, Li MC, Demayo FJ, Linnoila I, Deng CX, Lee EY, Medina D, Shih JH, Green JE.

Cancer Res. 2007 Sep 1;67(17):8065-80. Erratum in: Cancer Res. 2007 Oct 15;67(20):10097.

Items per page

Supplemental Content

Loading ...
Support Center